Dassault Systèmes (DSY) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
23 Feb, 2026Governance transition and leadership changes
Pascal Daloz is appointed Chairman and CEO, succeeding Bernard Charlès, effective February 21, 2026, with unanimous board support and a focus on continuity.
Bernard Charlès steps down as Executive Chairman and board member for personal reasons after 43 years of leadership and innovation, but will remain available as a product and technology advisor, maintaining some client relationships.
Succession planning was reviewed annually, ensuring a smooth and swift transition.
The board structure remains robust, with high independence and alignment to governance standards.
Charles Edelstenne, Founder and Honorary Chairman, expresses confidence in the new leadership.
Strategic vision and operational focus
The company is committed to leading the Industrial AI transformation with its 3D UNIV+RSES platform and the 7th generation of AI-based industry solutions.
Strategic priorities include redeploying product offerings, aligning go-to-market strategies, and redesigning the business model for AI-driven solutions.
No major strategic shifts are planned beyond the current focus on 3D UNIV+RSES and AI.
The transition is positioned as both continuity and acceleration, building on a strong legacy while entering a new phase.
Focus remains on redefining industry innovation and maintaining a game-changing position in the Generative Economy.
Management and organizational updates
Recent management changes include new leadership for Centric and Medidata, with external hires to strengthen go-to-market and transformation efforts.
Additional hires from AWS and McKinsey are aimed at enhancing enterprise solutions and global transformation.
The executive team is being reinforced to accelerate indirect channel transformation and operational efficiency.
Latest events from Dassault Systèmes
- FY25 revenue up 4% to €6,240M, strong recurring/cloud growth; FY26 targets 3–5% growth.DSY
Q4 2025 Investor Call11 Feb 2026 - FY26 targets 3–5% revenue growth, margin expansion, and strong ARR momentum.DSY
Q4 202511 Feb 2026 - Revenue and EPS rose, with robust cloud and 3DEXPERIENCE growth; outlook remains strong.DSY
Q2 20249 Feb 2026 - Q2 revenue up 6%, guidance reaffirmed, strong 3DEXPERIENCE and cloud growth.DSY
Q2 20259 Feb 2026 - Q3 saw 5% revenue growth, margin expansion, and strong recurring revenue momentum.DSY
Q3 20253 Feb 2026 - 5% revenue growth, 30.1% margin, and strong subscription momentum despite Life Sciences headwinds.DSY
Q3 2025 Investor Call3 Feb 2026 - Revenue and EPS guidance lowered for 2024, but H2 outlook and strategic focus remain strong.DSY
Guidance3 Feb 2026 - Strong H1 growth from 3DEXPERIENCE and cloud, with robust outlook despite deal delays.DSY
Q2 2024 Investor Call2 Feb 2026 - Q3 revenue up 4% to €1.46B; EPS guidance reaffirmed, with Q4 growth acceleration expected.DSY
Q3 202418 Jan 2026